Detalhe da pesquisa
1.
Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.
Dig Dis Sci
; 68(12): 4499-4510, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804353
2.
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B.
J Viral Hepat
; 29(11): 986-993, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048970
3.
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients.
J Viral Hepat
; 28(1): 51-60, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32896948
4.
Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.
Dig Dis Sci
; 66(2): 434-441, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239377
5.
Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America.
Ann Hepatol
; 19(4): 437-445, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32139262
6.
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).
Gut
; 68(12): 2206-2213, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462554
7.
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B.
Liver Int
; 39(8): 1418-1427, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30912219
8.
Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.
J Hepatol
; 2017 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844936
9.
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.
Gut
; 65(8): 1347-58, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934760
10.
Factors associated with knowledge and awareness of Hepatitis B in individuals of Chinese descent: Results from a mass point of care testing and outreach campaign in Toronto, Canada.
Can Liver J
; 7(1): 28-39, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38505784
11.
Health state utilities and quality of life in patients with hepatitis B.
Can J Gastroenterol
; 26(7): 445-51, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22803020
12.
Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B.
GastroHep
; 3(3): 196-208, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34421369
13.
Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis.
Aliment Pharmacol Ther
; 51(4): 457-468, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943262
14.
Sociocultural factors that potentially affect the institution of prevention and treatment strategies for prevention of hepatitis B in Chinese Canadians.
Can J Gastroenterol
; 23(1): 31-6, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19172206
15.
Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.
Can J Gastroenterol
; 20(7): 479-85, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16858501
16.
Diffuse skin reaction in patient with hepatitis B, treated with two different formulations of pegylated interferon.
Can J Gastroenterol
; 19(11): 677-8, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16292363
17.
The depiction of stigmatization in research about hepatitis C.
Int J Drug Policy
; 18(5): 364-73, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17854724